Bonum Therapeutics

Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.

Research Seattle, United States ~22 employees Private · Series A

Work at Bonum Therapeutics in HR or recruiting? Claim this page

Employees
22
0% in the 3 months to Sep 2026
Revenue / employee
$266K
Revenue ~$5.8M
Total funding
$125M
Last round Series A, Nov 2022
12-month attrition
11.7%
Tech: 0%
H1B sponsor
NA

Headcount trend

Bonum Therapeutics went from 25 employees in Oct 2024 to 22 in Sep 2026. Apr to Sep 2026: 0 people joined, 3 left.

Funding rounds

Total funding$125M
Funding rounds4
Investors10

Org structure

Headcount by department

Other18
Operations2
Engineering1
Sales1

Bonum Therapeutics FAQ

How many employees does Bonum Therapeutics have?

Bonum Therapeutics has about 22 employees, unchanged over the 3 months to Sep 2026.

What is Bonum Therapeutics's revenue per employee?

Bonum Therapeutics makes about $266K in revenue per employee, based on $5.85M annual revenue and 22 employees.

How much funding has Bonum Therapeutics raised?

Bonum Therapeutics has raised $125.33M in total funding; its latest round was Series A in Nov 2022.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.